EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Psychiatric‐onset neuronal intranuclear inclusion disease in a psychiatry‐based dementia‐enriched cohort in Japan

Tesshin Miyamoto iD, Kohji Mori iD, Shoshin Akamine iD, Shizuko Kondo, Shiho Gotoh iD, Ryota Uozumi iD, Sumiyo Umeda iD, Hanako Koguchi-Yoshioka iD, Satoshi Nojima iD, Daiki Taomoto iD, Yuto Satake iD, Takashi Suehiro und 4 weitere

Psychiatry and Clinical Neurosciences · 2025

DOI: 10.1111/pcn.13854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychiatry and Clinical Neurosciences, 2025. Verfasst von Tesshin Miyamoto und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Graduate School of Medicine, The University of Osaka, Osaka, Japan. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Dementia, Neurodegenerative Diseases. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JSPS KAKENHI, JST FOREST Program, AMED.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

A GGC repeat expansion in the 5′ untranslated region of NOTCH2NLC is a genetic cause of Neuronal Intranuclear Inclusion Disease (NIID) that exhibits cognitive, motor, and autonomic dysfunction. Our objective is to determine whether there are undiagnosed NIID cases in a psychiatry‐based dementia‐enriched cohort and to identify their clinical characteristics.

Methods

A retrospective clinical cohort study was conducted in an inpatient and outpatient psychiatric clinic in a University Hospital in Osaka, Japan. Genomic DNA and clinical information were collected with written informed consent. Nine hundred fifty‐eight cases were clinically classified according to the International Classification of Diseases (ICD)‐10 system. Genetic analysis with Repeat‐Primed PCR and Amplicon‐Length PCRs were performed.

Results

Of the 958 cases, three were confirmed to have an aberrant GGC repeat expansion in NOTCH2NLC . Cases 1 and 2 had preceding anxiety and depressive episodes, and one of these cases also had a mild cognitive impairment. Case 3 met the diagnostic criteria for progressive supranuclear palsy. All three cases lacked hyperintensity at the corticomedullary border on diffusion‐weighted MRI, which is known as a characteristic for NIID. Interestingly, one case exhibited the corticomedullary hyperintensity later in the disease course with apparent neurocognitive decline. All three cases exhibited a mix of slow waves in electroencephalogram and elevated total protein level in cerebrospinal fluid.

Conclusions

NIID is a rare cause of cognitive dysfunction in a psychiatry‐based dementia‐enriched cohort in Japan. Our data implicates psychiatric symptoms can be prodromal or early manifestation of a subset of NIID cases, thereby extending its phenotypic spectrum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionDementiaNeurodegenerative DiseasesAgedAged, 80 and overFemaleHumansMaleMiddle AgedCohort StudiesIntranuclear Inclusion BodiesJapanRetrospective StudiesTrinucleotide Repeat ExpansionNerve Tissue ProteinsIntercellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

NOTCH2NLCNeuronal Intranuclear Inclusion Diseaseneurodegenerative diseaserepeat diseaserepeat primed PCR

Substanzen

NOTCH2NLC protein, humanNerve Tissue ProteinsIntercellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Psychiatry, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
  • Department of Neurocutaneous Medicine, Division of Health Science, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
  • Department of Pathology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
  • Division of Psychiatry, University College London, London, UK.
  • Health and Counseling Center, The University of Osaka, Toyonaka, Japan.

ORCID-Profile: Tesshin Miyamoto, Kohji Mori, Shoshin Akamine, Shiho Gotoh, Ryota Uozumi, Sumiyo Umeda, Hanako Koguchi-Yoshioka, Satoshi Nojima, Daiki Taomoto, Yuto Satake, Hideki Kanemoto, Takashi Morihara

Förderung

  • JSPS KAKENHI
  • JST FOREST Program
  • AMED
  • SENSHIN Medical Research Foundation
  • The Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • Takeda Science Foundation
  • Japan Agency for Medical Research and Development

Zitieren

APA

Miyamoto, T., Mori, K., Akamine, S., Kondo, S., Gotoh, S., Uozumi, R., Umeda, S., Koguchi-Yoshioka, H., Nojima, S., Taomoto, D., Satake, Y., Suehiro, T., Kanemoto, H., Yoshiyama, K., Morihara, T., & Ikeda, M. (2025). Psychiatric‐onset neuronal intranuclear inclusion disease in a psychiatry‐based dementia‐enriched cohort in Japan. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.13854

Vancouver

Miyamoto T, Mori K, Akamine S, Kondo S, Gotoh S, Uozumi R, et al. Psychiatric‐onset neuronal intranuclear inclusion disease in a psychiatry‐based dementia‐enriched cohort in Japan. Psychiatry and Clinical Neurosciences. 2025. doi:10.1111/pcn.13854

BibTeX
@article{Miyamoto2025,
  author = {Miyamoto, Tesshin and Mori, Kohji and Akamine, Shoshin and Kondo, Shizuko and Gotoh, Shiho and Uozumi, Ryota and Umeda, Sumiyo and Koguchi-Yoshioka, Hanako and Nojima, Satoshi and Taomoto, Daiki and Satake, Yuto and Suehiro, Takashi and Kanemoto, Hideki and Yoshiyama, Kenji and Morihara, Takashi and Ikeda, Manabu},
  title = {Psychiatric‐onset neuronal intranuclear inclusion disease in a psychiatry‐based dementia‐enriched cohort in Japan},
  journal = {Psychiatry and Clinical Neurosciences},
  year = {2025},
  doi = {10.1111/pcn.13854}
}
Kostenlos starten →